Drug Profile
Methylsulfasalazine
Latest Information Update: 02 Sep 2002
Price :
$50
*
At a glance
- Originator Unknown
- Class Antirheumatics; Sulfonamides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 20 Mar 1996 Dicontinued for Inflammation